2008 Conference on Cell Replacement in the Inner Ear
2008 Conference on Cell Replacement in the Inner Ear
批准号:
7406897
负责人:
George A. Gates
金额:
$5.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-25 至 2009-03-31
关键词:
AffectAreaAuditoryBasic ScienceBiologyBypassCell ProliferationCellsCochlear NerveCollaborationsDataDiseaseDizzinessEducationEducational StatusEpitheliumEquilibriumFosteringFutureGoalsHabilitationHair CellsHearingHearing AidsInternationalLabyrinthLeadLifeMammalsMolecular GeneticsNatural regenerationProcessPublic HealthPurposeRehabilitation therapyResearchResearch PersonnelScientistSensorySensory DisordersSensory HairStem cellsStria VascularisSystemTechnologyTimeTreatment CostUnited StatesVestibular lossWalkingWorkcell injurycell typeclinical applicationdayexperiencefundamental researchhearing impairmentimprovedinsightinterestlateral linerestorationsoundsymposiumtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Partial support is requested for a 3-day international conference on fundamental research in the emerging field of cell replacement, with special emphasis on the inner ear. The conference will be held in Bethesda, MD from June 12-15 in 2008. The conference will be the third major conference on the topic of inner ear regeneration held in the U.S., the last one being over 10 years ago. This meeting is very timely and justified by substantial advances in several areas of sensory regenerative biology, including in the inner ear. The proposed meeting has three general purposes: 1) to provide opportunities for focused education in regenerative biology, 2) to promote discussion of current scientific data and prioritization of future directions for inner ear regeneration, and 3) to enhance collaborations between U.S. and international investigators, which are recognized as vital to accelerating progress in the field. Recent discoveries have affirmed the potential for restoration of hearing and balance through replacing missing or damaged cells (sensory and non-sensory) in the inner ear. The proposed meeting will provide a forum for researchers from a variety of backgrounds and educational levels to present findings pertaining to mechanisms regulating important steps of regeneration, including progenitor cell proliferation, cellular differentiation, and functional maturation, in the auditory, vestibular, and lateral line systems. The meeting is organized into specific sessions/topic areas that help to direct and focus the educational experience. In each session, scientists from other fields with significant insight into fundamental regenerative mechanisms will share their latest findings. Subsequently, investigators in inner ear regeneration will present their recent work. Ample time will be allotted for researchers to discuss their work and to compare and contrast data within and across systems. Major emphasis will be placed on the discussion of current tools available at the cellular, molecular, and genetic levels for approaching specific scientific questions in the inner ear and in other systems. Additional emphasis will be placed on considerations that impact potential clinical applications to achieve cellular regeneration in mammals. Public Health Relevance Statement
Sensory disorders of the inner ear occur frequently, affecting people world-wide and in all walks of life. In the United States alone, 30 million people have hearing loss, and 95 million people will complain to their doctors of dizziness at least once in their lifetime. The cost of treatment, habilitation, and rehabilitation of hearing and balance problems results in a substantial societal burden. The main cause of hearing and balance disorders is the irreversible loss of sensory hair cells in inner ear sensory epithelia; however, other ailments of the inner ear, including changes in the stria vascularis, also lead to hearing deficits. Current treatments for hearing loss involve sound amplification via hearing aids or direct stimulation of the cochlear nerve, bypassing the damaged sensory epithelium. There are no known treatments for loss of vestibular function. Restoration of the sensory epithelium and the other affected cell types promises to provide improved return of auditory and vestibular processing following damage. The goal of the conference is to foster the exchange of research information, ideas, tools, and technologies among investigators from across the world who share an interest in regenerative biology. The meeting will discuss recent basic science discoveries and will highlight important directions for future research. This interchange should invigorate and focus research in inner ear hearing regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deafness Research Foundation Clinical Research Workshop
-
批准号:7001941
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2005
-
负责人:George A. Gates
-
依托单位:
Deafness Research Foundation Clinical Research Workshop
-
批准号:6838453
-
项目类别:
-
资助金额:$3.3万
-
财政年份:2004
-
负责人:George A. Gates
-
依托单位:
Deafness Research Foundation Clinical Research Workshop
-
批准号:6605616
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2003
-
负责人:George A. Gates
-
依托单位:
Barany Society XXII Regular Meeting, Seattle, WA USA
-
批准号:6580082
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2002
-
负责人:George A. Gates
-
依托单位:
Symposium on the Biology of Noise Damage to the Ear
-
批准号:6318125
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2001
-
负责人:George A. Gates
-
依托单位:
OUTCOMES RESEARCH IN OTOLARYNGOLOGY
-
批准号:2128262
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1995
-
负责人:George A. Gates
-
依托单位:
Presbycusis: Biomedical Risk Factors
-
批准号:6910920
-
项目类别:
-
资助金额:$38.16万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
Presbycusis: Biomedical Risk Factors
-
批准号:6771734
-
项目类别:
-
资助金额:$34.7万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:2443601
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:2126554
-
项目类别:
-
资助金额:$24.55万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:2853551
-
项目类别:
-
资助金额:$37.98万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:3218146
-
项目类别:
-
资助金额:$25.97万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:6379305
-
项目类别:
-
资助金额:$30.9万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:2126552
-
项目类别:
-
资助金额:$26.32万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:2126551
-
项目类别:
-
资助金额:$18.16万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
Presbycusis: Biomedical Risk Factors
-
批准号:6933740
-
项目类别:
-
资助金额:$5.42万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:6175508
-
项目类别:
-
资助金额:$36.44万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
Presbycusis: Biomedical Risk Factors
-
批准号:6684195
-
项目类别:
-
资助金额:$37.94万
-
财政年份:1993
-
负责人:George A. Gates
-
依托单位:
PRESBYCUSIS--BIOMEDICAL RISK FACTORS
-
批准号:3218145
-
项目类别:
-
资助金额:$30.15万
-
财政年份:1992
-
负责人:George A. Gates
-
依托单位:
METHODS IN CLINICAL OTOLARYNGOLOGIC RESEARCH
-
批准号:3436040
-
项目类别:
-
资助金额:$1.0万
-
财政年份:1986
-
负责人:George A. Gates
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: